Renaissance Technologies (RenTech)'s IMCR Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 164,000 shares of Immunocore Holdings plc (IMCR) worth $4.94 M, representing 0.01% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in IMCR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 219,700 shares. Largest reduction occurred in Q3 2024, reducing 370,720 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Immunocore Holdings plc (IMCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunocore Holdings plc (IMCR) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +23,100 | Add 16.39% | 164,000 | $30.15 |
| Q4 2025 | -1,870 | Reduce 1.31% | 140,900 | $34.71 |
| Q3 2025 | -79,282 | Reduce 35.70% | 142,770 | $36.33 |
| Q2 2025 | +131,482 | Add 145.17% | 222,052 | $31.38 |
| Q1 2025 | -6,000 | Reduce 6.21% | 90,570 | $29.67 |
| Q4 2024 | -179,630 | Reduce 65.04% | 96,570 | $29.50 |
| Q3 2024 | -370,720 | Reduce 57.31% | 276,200 | $31.13 |
| Q2 2024 | +82,120 | Add 14.54% | 646,920 | $33.89 |
| Q1 2024 | +219,700 | Add 63.66% | 564,800 | $65.00 |
| Q4 2023 | -111,200 | Reduce 24.37% | 345,100 | $68.32 |
| Q3 2023 | +9,000 | Add 2.01% | 456,300 | $51.90 |
| Q2 2023 | +2,700 | Add 0.61% | 447,300 | $0.06 |
| Q1 2023 | +139,500 | Add 45.72% | 444,600 | $0.05 |
| Q4 2022 | +210,300 | Add 221.84% | 305,100 | $0.06 |
| Q3 2022 | +43,900 | Add 86.25% | 94,800 | $46.94 |
| Q2 2022 | +43,600 | Add 597.26% | 50,900 | $37.31 |
| Q1 2022 | +7,300 | New Buy | 7,300 | $29.86 |
Renaissance Technologies (RenTech)'s Immunocore Holdings plc Investment FAQs
Renaissance Technologies (RenTech) first purchased Immunocore Holdings plc (IMCR) in Q1 2022, acquiring 7,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Immunocore Holdings plc (IMCR) for 17 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Immunocore Holdings plc (IMCR) was in Q1 2024, adding 564,800 shares worth $36.71 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 164,000 shares of Immunocore Holdings plc (IMCR), valued at approximately $4.94 M.
As of the Q1 2026 filing, Immunocore Holdings plc (IMCR) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Immunocore Holdings plc (IMCR) was 646,920 shares, as reported at the end of Q2 2024.